Entry |
|
Symbol |
NFKB1
|
Name |
(RefSeq) nuclear factor NF-kappa-B p105 subunit isoform X1
|
KO |
K02580 | nuclear factor NF-kappa-B p105 subunit |
|
Organism |
fca Felis catus (domestic cat)
|
Pathway |
fca04613 | Neutrophil extracellular trap formation |
fca04620 | Toll-like receptor signaling pathway |
fca04621 | NOD-like receptor signaling pathway |
fca04622 | RIG-I-like receptor signaling pathway |
fca04625 | C-type lectin receptor signaling pathway |
fca04658 | Th1 and Th2 cell differentiation |
fca04660 | T cell receptor signaling pathway |
fca04662 | B cell receptor signaling pathway |
fca04920 | Adipocytokine signaling pathway |
fca04932 | Non-alcoholic fatty liver disease |
fca04933 | AGE-RAGE signaling pathway in diabetic complications |
fca05022 | Pathways of neurodegeneration - multiple diseases |
fca05163 | Human cytomegalovirus infection |
fca05166 | Human T-cell leukemia virus 1 infection |
fca05167 | Kaposi sarcoma-associated herpesvirus infection |
fca05168 | Herpes simplex virus 1 infection |
fca05170 | Human immunodeficiency virus 1 infection |
fca05202 | Transcriptional misregulation in cancer |
fca05207 | Chemical carcinogenesis - receptor activation |
fca05208 | Chemical carcinogenesis - reactive oxygen species |
fca05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
fca05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:fca00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100142683 (NFKB1)
04014 Ras signaling pathway
100142683 (NFKB1)
04064 NF-kappa B signaling pathway
100142683 (NFKB1)
04668 TNF signaling pathway
100142683 (NFKB1)
04066 HIF-1 signaling pathway
100142683 (NFKB1)
04071 Sphingolipid signaling pathway
100142683 (NFKB1)
04024 cAMP signaling pathway
100142683 (NFKB1)
04151 PI3K-Akt signaling pathway
100142683 (NFKB1)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100142683 (NFKB1)
04218 Cellular senescence
100142683 (NFKB1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
100142683 (NFKB1)
04620 Toll-like receptor signaling pathway
100142683 (NFKB1)
04621 NOD-like receptor signaling pathway
100142683 (NFKB1)
04622 RIG-I-like receptor signaling pathway
100142683 (NFKB1)
04623 Cytosolic DNA-sensing pathway
100142683 (NFKB1)
04625 C-type lectin receptor signaling pathway
100142683 (NFKB1)
04660 T cell receptor signaling pathway
100142683 (NFKB1)
04658 Th1 and Th2 cell differentiation
100142683 (NFKB1)
04659 Th17 cell differentiation
100142683 (NFKB1)
04657 IL-17 signaling pathway
100142683 (NFKB1)
04662 B cell receptor signaling pathway
100142683 (NFKB1)
04062 Chemokine signaling pathway
100142683 (NFKB1)
09152 Endocrine system
04920 Adipocytokine signaling pathway
100142683 (NFKB1)
04917 Prolactin signaling pathway
100142683 (NFKB1)
04926 Relaxin signaling pathway
100142683 (NFKB1)
09156 Nervous system
04722 Neurotrophin signaling pathway
100142683 (NFKB1)
09158 Development and regeneration
04380 Osteoclast differentiation
100142683 (NFKB1)
09149 Aging
04211 Longevity regulating pathway
100142683 (NFKB1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100142683 (NFKB1)
05202 Transcriptional misregulation in cancer
100142683 (NFKB1)
05206 MicroRNAs in cancer
100142683 (NFKB1)
05207 Chemical carcinogenesis - receptor activation
100142683 (NFKB1)
05208 Chemical carcinogenesis - reactive oxygen species
100142683 (NFKB1)
05203 Viral carcinogenesis
100142683 (NFKB1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100142683 (NFKB1)
09162 Cancer: specific types
05212 Pancreatic cancer
100142683 (NFKB1)
05221 Acute myeloid leukemia
100142683 (NFKB1)
05220 Chronic myeloid leukemia
100142683 (NFKB1)
05215 Prostate cancer
100142683 (NFKB1)
05222 Small cell lung cancer
100142683 (NFKB1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100142683 (NFKB1)
05170 Human immunodeficiency virus 1 infection
100142683 (NFKB1)
05161 Hepatitis B
100142683 (NFKB1)
05160 Hepatitis C
100142683 (NFKB1)
05171 Coronavirus disease - COVID-19
100142683 (NFKB1)
05164 Influenza A
100142683 (NFKB1)
05162 Measles
100142683 (NFKB1)
05168 Herpes simplex virus 1 infection
100142683 (NFKB1)
05163 Human cytomegalovirus infection
100142683 (NFKB1)
05167 Kaposi sarcoma-associated herpesvirus infection
100142683 (NFKB1)
05169 Epstein-Barr virus infection
100142683 (NFKB1)
05165 Human papillomavirus infection
100142683 (NFKB1)
09171 Infectious disease: bacterial
05132 Salmonella infection
100142683 (NFKB1)
05135 Yersinia infection
100142683 (NFKB1)
05133 Pertussis
100142683 (NFKB1)
05134 Legionellosis
100142683 (NFKB1)
05152 Tuberculosis
100142683 (NFKB1)
09174 Infectious disease: parasitic
05146 Amoebiasis
100142683 (NFKB1)
05145 Toxoplasmosis
100142683 (NFKB1)
05140 Leishmaniasis
100142683 (NFKB1)
05142 Chagas disease
100142683 (NFKB1)
09163 Immune disease
05321 Inflammatory bowel disease
100142683 (NFKB1)
09164 Neurodegenerative disease
05010 Alzheimer disease
100142683 (NFKB1)
05022 Pathways of neurodegeneration - multiple diseases
100142683 (NFKB1)
09165 Substance dependence
05030 Cocaine addiction
100142683 (NFKB1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100142683 (NFKB1)
05418 Fluid shear stress and atherosclerosis
100142683 (NFKB1)
05415 Diabetic cardiomyopathy
100142683 (NFKB1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100142683 (NFKB1)
04932 Non-alcoholic fatty liver disease
100142683 (NFKB1)
04931 Insulin resistance
100142683 (NFKB1)
04933 AGE-RAGE signaling pathway in diabetic complications
100142683 (NFKB1)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
100142683 (NFKB1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:fca03000]
100142683 (NFKB1)
Transcription factors [BR:fca03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Rel/Ankyrin
100142683 (NFKB1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
B1:complement(119413627..119532673)
|
AA seq |
968 aa
MAEDDSYLGAHEQMFHLDPLTHTIFNPEIFQPEMPLPTADGPYLQILEQPKQRGFRFRYV
CEGPSHGGLPGASSEKNKKSYPQVKICNYMGPAKVIVQLVTNGKNIHLHAHSLVGKHCED
GICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACTKGYNPGLLVHPDLAYLQA
EGGGDRQLTDREKEIIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIY
DSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGIWEGFGDF
SPTDVHRQFAIVFKTPKYKDVNITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQ
RKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGAGGTGPGYGFPHYGFPTYGGITFH
PGTTKSNAGMKHGTIDSPSKNDPEGCSKSVERDTLNLSGKVTEPTEQDKESGTGEDEVTL
TYTVGVKEENSRFQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENG
DSVLHLAIIHLHAQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEAVVEDLLK
AGADLSLLDRLGNSVLHLAAKEGQDKILSVLLKHKKAALLIDHPNGEGLTAIHIAVMSNS
MACLLLLVAAGADVNAQERKSGRSALHLAVERDNISLAGCLLLEGDAYVDSTTYDGTTPL
HIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWEKDGEDEGVVPGTTPLDMATNWQ
VFDILNGKPYEPEFTSDDLLAQGDMKQLTEDAKLQLYKLLEIPDPDKNWATLAQKLGLGI
LNNAFRLSPAPSKTLMDNYEVSGGTIKELVEALRQMGYTEAIEVIQAAFCTPGTAAPSPG
KTLSLPLSPASTRSPVDEVRDDSICDSGVETSFRKLSFTESLTGGGSLLTLNKVPREYGR
EGPIEGKI |
NT seq |
2907 nt +upstreamnt +downstreamnt
atggcagaagacgattcatatttgggagcacatgaacaaatgtttcatttggatcctttg
actcatacgatattcaatccagaaatatttcaaccagagatgcccctacctacagcagat
ggtccataccttcaaatattagagcaacctaaacagagaggatttcgtttccgttatgta
tgtgaaggcccatcccatggtggactcccgggtgcgtctagtgaaaagaacaagaagtcc
taccctcaggtcaaaatctgcaactatatgggacctgcaaaggttattgttcagttggtc
acaaatggaaaaaacatccacctgcatgcacacagcctggtgggaaaacactgtgaggat
gggatctgcactgtaaccgccggacccaaggacatggtggtcggctttgcaaacttaggt
atacttcatgtgacaaagaaaaaagtatttgaaacactggaagcacgaatgacagaggca
tgtacaaagggctacaatcccggacttctggtacatcctgatcttgcctatttgcaagca
gaagggggaggagaccgacagctcacggatcgggaaaaggaaatcatccgccaggcagct
cttcagcagacaaaggagatggacctcagcgtggtgcggctcatgtttacagcttttctc
ccagatagcaccggcagcttcacaaggcgcctggaacccgtggtatcggatgccatctat
gacagcaaagcccccaatgcgtccaacttgaaaattgtaagaatggacaggacagctgga
tgtgtaactggaggggaagagatttaccttctctgtgacaaggttcagaaagatgacatc
caaattcgattttatgaagaggaggaaaatggtggaatctgggaaggatttggagatttt
tctcccacagatgttcatagacaatttgccatcgtcttcaaaacgccaaagtacaaagat
gtcaacatcacaaaaccggcttccgtatttgtccaacttcggaggaaatctgatttggaa
actagcgaacccaaaccttttctctactaccctgaaatcaaagataaagaggaagtgcag
aggaaacggcagaagctcatgcctaatttctctgatagtttcggcggcggtagtggtgct
ggagctggaggtggaggcatgtttggcagtggcggtggaggagggggtgccggaggtacg
ggtccagggtatggcttcccccactatggattccctacatacggtggaattaccttccat
cctggaaccactaaatctaatgccgggatgaaacatggaaccatagactccccatctaaa
aatgaccctgagggttgcagcaagagtgtggagagagacacattgaacctctctgggaaa
gtaactgaacccacagaacaagataaggagtctggcactggagaagatgaagttaccctg
acgtatacagtaggagtaaaggaagagaattctaggtttcaggataacctcttcctagag
aaggctatgcagctggccaagcggcatgccaatgccctttttgactacgcagtgacagga
gatgtgaagatgctgctggctgttcagcgccatctcactgcagtgcaggatgagaatggg
gacagtgtcttacacttagcaatcatccatcttcatgcccagcttgtgagggatctacta
gaagtcacgtctggcttgatttctgatgacattatcaatatgagaaatgatctctaccag
acacccttgcacttggccgtgatcaccaagcaggaggctgtggtggaggacttgctgaag
gccggggctgacctgagcctcctggaccgcttgggtaactctgttttgcacctagctgcc
aaagaaggacaagataaaattctcagtgttttactcaagcacaaaaaggcagcactactt
atcgaccaccctaatggggaaggtctaaccgccattcacatagccgtgatgagcaacagt
atggcgtgcctgttgctgctggtggccgccggggccgacgtcaacgcccaggagaggaag
tcggggcgctcggcgctgcacctggctgtggagcgtgacaacatctcccttgctggctgt
ctgctcctggagggtgatgcctatgtagacagtaccacatatgatggaactacacccctg
cacatagcagccgggagagggtccaccaggctggcggctcttctcaaagcagcaggcgca
gatcccctcgtggagaactttgagcctctctatgacctggatgactcttgggaaaaagat
ggagaggatgaaggagtcgtgcctggaaccacacctctagatatggccaccaactggcag
gtgttcgatatattaaatgggaaaccatatgagccagagtttacatccgatgatttactc
gcacaaggagacatgaaacagctgactgaagatgccaagttgcagctctacaagttgcta
gaaatccctgatccagacaaaaactgggctaccctggcacagaagttaggcctggggata
ctaaataatgccttccggctgagtcccgctccttctaaaactcttatggacaactacgag
gtctctggggggacaattaaagagctggtggaggccctgagacagatgggctataccgaa
gcgatcgaagtgatccaggccgccttctgcaccccgggaactgcagcccccagcccaggg
aagaccctctcactgcccctctcacctgcctccacaaggtcaccagtagacgaggtccgg
gacgacagcatctgtgacagcggcgtggagacctccttccgcaaactcagctttacagag
tctctgaccggcggcggctccttgctgactcttaacaaagtgccccgtgagtacgggcgg
gaaggacctatagaaggcaaaatctag |